Comparison of positive airway pressure efficacy in obese hypercapnic overlap syndrome.

Y. Zheng (Sydney (NSW), Australia), B. Yee (Sydney (NSW), Australia), K. Wong (Sydney (NSW), Australia), A. Piper (Sydney (NSW), Australia)

Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Disease area: Airway diseases, Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Zheng (Sydney (NSW), Australia), B. Yee (Sydney (NSW), Australia), K. Wong (Sydney (NSW), Australia), A. Piper (Sydney (NSW), Australia). Comparison of positive airway pressure efficacy in obese hypercapnic overlap syndrome.. 1957

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 568s
Year: 2004

Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005

Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012

Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

Long-term echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome?
Source: Sleep and Breathing Conference 2021
Year: 2021


Does continuous positive airway pressure (CPAP) improve the exercise capacity of adults with tracheomalacia?
Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Year: 2018

Effects of different levels of nasal continuous positive airways pressure (CPAP) in infants with severe acute bronchiolitis
Source: Eur Respir J 2006; 28: Suppl. 50, 264s
Year: 2006

Effects of continuous positive airways pressure (CPAP) on portal flow in patients with obstructive apnoea syndrome (OSAS)
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007

Long-term positive airway pressure therapy in obesity hypoventilation syndrome. Cost study
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019


The influence of continuous positive airway pressure (CPAP) on response to incremental exercise in sleep apnea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 567s
Year: 2004

Long term positive airway pressure effectiveness in obesity hypoventilation syndrome. Pickwick study results
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018



A comparison of different nasal positive pressure ventilation systems for the treatment of apnea of prematurity
Source: Annual Congress 2006 - Premature infants, bronchopulmonary dysplasia, prediction, aetiology and treatment
Year: 2006


Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Continuous positive airway pressure treatment in patients with OSA
Source: Eur Respir Mon 2010; 50: 244-266
Year: 2010


Predictors of continuous positive airway pressure (CPAP) response in severe hypoxaemic respiratory failure due to COVID-19 pneumonitis
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


Bi-level positive airways pressure ventilation (BIPAP) versus continuous positive airway pressure (CPAP) for treatment of sleep disordered breathing (SDB) in patients with Prader – Willi syndrome (PWS)
Source: Annual Congress 2008 - Noninvasive ventilation in the chronic setting
Year: 2008

Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018